Information Provided By: 
Fly News Breaks for December 13, 2017
EVHC
Dec 13, 2017 | 05:36 EDT
Piper Jaffray analyst Austin Quackenbush started Envision Healthcare with a Neutral rating and $35 price target. The analyst is cautious on Envision citing the "increasing consumerism of healthcare," which he believes will negatively impact volumes in the near-mid term. The analyst, however, would not be surprised if the company were taken out given the reported interest from private equity.
News For EVHC From the Last 2 Days
There are no results for your query EVHC
